Total Payments
$2,471
2024 Payments
$1,932
Companies
14
Transactions
147
Medicare Patients
25
Medicare Billing
$4,613
Payment Breakdown by Category
Food & Beverage$2,471 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,471 | 147 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $447.55 | 21 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $329.34 | 26 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $300.35 | 13 | $0 (2024) |
| Alkermes, Inc. | $280.24 | 14 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $217.04 | 17 | $0 (2024) |
| Lundbeck LLC | $203.33 | 20 | $0 (2024) |
| ABBVIE INC. | $201.57 | 11 | $0 (2024) |
| ITI, Inc. | $198.43 | 9 | $0 (2023) |
| Axsome Therapeutics, Inc. | $95.63 | 4 | $0 (2024) |
| Corium, LLC | $89.51 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,932 | 119 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($447.55) |
| 2023 | $539.90 | 28 | ITI, Inc. ($198.43) |
All Payment Transactions
147 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Central Nervous System | ||||||
| 12/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.32 | General |
| Category: Central Nervous System | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/11/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: CNS | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $32.48 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $19.50 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 12/03/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $0.62 | General |
| Category: PSYCHIATRY | ||||||
| 12/02/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $20.70 | General |
| Category: Neuroscience | ||||||
| 11/30/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.77 | General |
| Category: PSYCHIATRY | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $2.59 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $19.89 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $3.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $0.98 | General |
| Category: Central Nervous System | ||||||
| 11/19/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: PSYCHIATRY | ||||||
| 11/18/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $9.06 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $0.40 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 25 | 69 | $8,715 | $4,613 |
Total Patients
25
Total Services
69
Medicare Billing
$4,613
Procedure Codes
2
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 33 | $5,115 | $2,905 | 56.8% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2023 | 13 | 36 | $3,600 | $1,708 | 47.5% |
About Laura Richard
Laura Richard is a Hospice healthcare provider based in West Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/11/2022. The National Provider Identifier (NPI) number assigned to this provider is 1770231482.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Laura Richard has received a total of $2,471 in payments from pharmaceutical and medical device companies, with $1,932 received in 2024. These payments were reported across 147 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($2,471).
As a Medicare-enrolled provider, Richard has provided services to 25 Medicare beneficiaries, totaling 69 services with total Medicare billing of $4,613. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospice
- Other Specialties Psychiatric/Mental Health
- Location West Warwick, RI
- Active Since 03/11/2022
- Last Updated 04/07/2023
- Taxonomy Code 163WH1000X
- Entity Type Individual
- NPI Number 1770231482
Products in Payments
- CAPLYTA (Drug) $645.98
- REXULTI (Drug) $393.60
- INGREZZA (Drug) $300.35
- LYBALVI (Drug) $231.54
- VRAYLAR (Drug) $201.57
- Austedo XR (Drug) $196.54
- Auvelity (Drug) $95.63
- Azstarys (Drug) $89.51
- NUEDEXTA (Drug) $81.81
- ARISTADA (Drug) $48.70
- ABILIFY MYCITE (Drug) $44.15
- Qelbree (Drug) $39.68
- SPRAVATO (Drug) $35.30
- UZEDY (Drug) $20.50
- COBENFY (Drug) $19.89
- PERSERIS (Drug) $13.59
- ABILIFY ASIMTUFII (Drug) $13.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.